MedTrace Logo

REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study

NCT04010045 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2021-11-03

No results posted yet for this study

Summary

This is an observational study of the DABRA Laser System and other medical devices intended for endovascular treatment of peripheral artery disease.

Conditions

Interventions

DEVICE

Endovascular Treatment of PAD

PAD endovascular treatment using the DABRA Laser System + other FDA cleared/ approved devices for the treatment of PAD.

Sponsors & Collaborators

  • Ra Medical Systems

    lead INDUSTRY

Principal Investigators

  • Jami Miller · Ra Medical Systems

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-02
Primary Completion
2020-10-15
Completion
2020-10-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010045 on ClinicalTrials.gov